“Trial in Progress: A Phase 3 Randomized Study of Low-Dose Intralesional Cemiplimab Versus Primary Surgery for Patients With Early-Stage Cutaneous Squamous Cell Carcinoma (CLEAR CSCC)”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s689. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/3845.